Bioinformatics drug development // Drug Repurposing

Bioinformatics drug development

Earlier this year a study by

Drug discovery and development is a complex, high risk, time consuming and potentially highly rewarding process. Pharmaceutical companies literally burn millions of dollar per drug to bring it to the market. The development of a new drug requires a technological expertise, human resources and huge capital investment. It also requires strict adherence to regulations on testing and manufacturing standards before a new drug comes into market and can be used in the general population, in fact, some time it fails to come into market. All these factors just increase the cost for a new chemical entity research and development. Two branches which made positive impact on drug designing process and reduce the overall cost and risk are Bioinformatics and Pharmacogenomics. Their practice in drug designing process made positive effect on overall process and they can accelerate various steps of drug designing, and reduce the cost and over all time. Current note focusses on the role of bioinformatics and pharmacogenomics in drug discovery and development process.

You might also like

FDA in industry's pocket

by Tek_Jansen

That regulatory agency has been "captured". They know about the problem
but somehow can't say no to the meat industry.
The EU and UK regulators aren't so weak:
A key concern is that the development of bugs that laugh at vancomycin (a last line of defense against bacteria that resist all other antibiotics) could lead to a "doomsday scenario" with bacterial epidemics reminiscent of the Dark Ages. In 1997, the European Union banned avoparcin, a drug related to vancomycin, from animal feed after studies linked it to the development of vancomycin-resistant bacteria

Springer Antimalarial Drug II: Current Antimalarial and New Drug Developments (Handbook of Experimental Pharmacology / Antimalarial Drugs)
Book (Springer)
  • Used Book in Good Condition

Gnosis v.

LAP LAMBERT Academic Publishing Method Development and Validations For Antimalarial Drugs: A Strategy of Method Development and Validations For Antimalarial in Formulations
Book (LAP LAMBERT Academic Publishing)
PN Evaluation of New Antimalarials. Development of New Antimalarial Drugs
Book (PN)
Nova Science Pub Inc Antimalarial Drug Research and Development (Pharmacology-Research, Safety Testing and Regulation)
Book (Nova Science Pub Inc)
LAP LAMBERT Academic Publishing Method Development and Validations For Antimalarial Drugs: A Strategy of Method Development and Validations For Antimalarial in Formulations [Paperback] [2012] (Author) Almustapha Lawal, Rabiu A. Umar, Mu'azu G. Abubakar
Book (LAP LAMBERT Academic Publishing)